A Proven Record of SuccessNisonCo has a proven track record of successful political advocacy for policy changes supporting the legalization of marijuana and other causes. These same capabilities have helped businesses in multiple sectors build, secure, and increase brand awareness in a consistently shifting cultural landscape.
An Unmatched NetworkWith over 1,300 active media contacts at over 2,900 outlets, NisonCo has an unmatched network of relationships with mainstream media, industy specific media, product reviewers, and thought leaders from around the country.
Outstanding Client ServiceAt NisonCo we put the needs of our clients first and foremost. We aren’t happy unless you are, and our current and former clients know this. That is why 9 out of 10 clients say they would hire NisonCo again.
Your Cause is Our CauseFrom sensible drug policy to renewable energy, your cause is aligned with our ideals. We work harder and smarter because we truly believe the work we do makes this world a better place. Work with us to achieve your dreams.
1,300+active media relationships
We maintain active relationships with over 1,300 reporters, thought leaders, and radio and TV hosts around the country.
1,000+client stories placed
We have placed over 1,000 stories in TV, radio, print, and online media outlets.
93%client satisfaction rating
100% of our clients responded to a survey saying they were either “Extremely satisfied” or “satisfied” with our services.
One-hundred percent of our clients have come from word-of-mouth referrals.
Evan Nison is the founder and owner of NisonCo. He is also the youngest member of the Board of Directors of NORML and sits on the Board of Directors of Students for Sensible Drug Policy.
Ethan Andersen is a drug law reform advocate and a Registered Lobbyist in the state of New Jersey, with a background in political consulting and grassroots advocacy.
Drew White is a Public Relations Consultant and Client Manager, who previously worked in the Impact Investment and Business Development field with the non-profit B Lab.